Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EMIT is a private commercial-stage medical device company focused on therapeutic warming products for the treatment and prevention of hypothermia. The company designs, develops, manufactures, and sells portable intravenous fluid and blood warming devices used in trauma, environmental exposure, and procedure-related settings. Its lead commercial product family is HypothermX, including the HX100 portable warmer and related sterile fluid-path configurations. EMIT appears to operate as a small US-based healthcare company rather than a drug-development biotech, with its business centered on emergency and interventional warming technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Emit Corporation.